X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-05-11 | MPLT | Hanson Kristopher | GC | S - Sale | $30.13 | -13,917 | 162,331 | -8% | -$419,263 | ||||||
| M | 2026-05-07 | MPLT | Kroeger Christopher A. | CEO | S - Sale | $28.47 | -68,491 | 1,613,519 | -4% | -$1,949,634 | |||||
2026-05-07 | MPLT | Foff Erin Pennock | Chief Medical Officer | S - Sale | $28.54 | -4,438 | 346,059 | -1% | -$126,640 | ||||||
2026-05-07 | MPLT | Lillie James Woodruff | Chief Scientific Officer | S - Sale | $28.28 | -721 | 242,729 | 0% | -$20,390 | ||||||
| M | 2026-05-04 | MPLT | Setia Vishwas | CFO | S - Sale | $28.17 | -36,371 | 356,256 | -9% | -$1,024,719 | |||||
| M | 2026-05-04 | MPLT | Foff Erin Pennock | Chief Medical Officer | S - Sale | $28.39 | -50,280 | 350,497 | -13% | -$1,427,594 | |||||
| M | 2026-05-04 | MPLT | Lillie James Woodruff | Chief Scientific Officer | S - Sale | $28.40 | -51,707 | 243,450 | -18% | -$1,468,251 | |||||
2026-05-04 | MPLT | Hanson Kristopher | GC | S - Sale | $27.89 | -13,917 | 176,248 | -7% | -$388,177 | ||||||
| M | 2026-05-04 | MPLT | Kroeger Christopher A. | CEO | S - Sale | $28.39 | -49,744 | 1,682,010 | -3% | -$1,412,236 | |||||
| M | 2026-04-27 | MPLT | Gillis Jonathan | CAAO, PAO | S - Sale | $29.89 | -69,835 | 181,219 | -28% | -$2,087,687 | |||||
2026-04-27 | MPLT | Kreitzer Anatol | Chief Discovery Officer | S - Sale | $29.66 | -45,422 | 211,190 | -18% | -$1,347,066 | ||||||
2026-04-15 | MPLT | Kreitzer Anatol | Chief Discovery Officer | S - Sale | $26.61 | -3,316 | 256,612 | -1% | -$88,239 | ||||||
2026-04-15 | MPLT | Gillis Jonathan | CAAO, PAO | S - Sale | $26.61 | -3,590 | 251,054 | -1% | -$95,530 | ||||||
| M | 2026-04-15 | MPLT | Hanson Kristopher | GC | S - Sale | $26.89 | -1,827 | 190,165 | -1% | -$49,134 | |||||
| M | 2026-04-15 | MPLT | Setia Vishwas | CFO | S - Sale | $26.89 | -2,922 | 392,627 | -1% | -$78,572 | |||||
| M | 2026-04-15 | MPLT | Lillie James Woodruff | Chief Scientific Officer | S - Sale | $27.16 | -4,513 | 295,157 | -2% | -$122,574 | |||||
| M | 2026-04-15 | MPLT | Foff Erin Pennock | Chief Medical Officer | S - Sale | $27.03 | -3,213 | 400,777 | -1% | -$86,859 | |||||
| M | 2026-04-15 | MPLT | Kroeger Christopher A. | CEO | S - Sale | $27.16 | -19,187 | 1,731,754 | -1% | -$521,146 | |||||
2026-04-15 | MPLT | Malenka Robert C. | Dir | S - Sale | $26.90 | -8,593 | 348,138 | -2% | -$231,152 | ||||||
| M | 2026-02-20 | MPLT | Malenka Robert C. | Dir | S - Sale | $18.34 | -14,195 | 356,731 | -4% | -$260,398 | |||||
| M | 2026-02-18 | MPLT | Pavlov George | Dir | P - Purchase | $17.65 | +25,000 | 25,000 | New | +$441,168 | |||||
2026-02-13 | MPLT | Malenka Robert C. | Dir | S - Sale | $18.21 | -12,116 | 370,926 | -3% | -$220,632 | ||||||
2026-02-10 | MPLT | Garnett Timothy John | Dir | P - Purchase | $17.89 | +14,124 | 63,649 | +29% | +$252,678 | ||||||
| M | 2026-02-10 | MPLT | Malenka Robert C. | Dir | S - Sale | $18.12 | -6,863 | 383,042 | -2% | -$124,329 | |||||
| M | 2026-02-02 | MPLT | Malenka Robert C. | Dir | S - Sale | $18.02 | -7,040 | 389,905 | -2% | -$126,861 | |||||
| M | 2026-01-28 | MPLT | Malenka Robert C. | Dir | S - Sale | $18.49 | -34,398 | 396,945 | -8% | -$635,857 | |||||
| D | 2025-10-28 | MPLT | Novo Holdings A/S | 10% | P - Purchase | $17.00 | +952,941 | 3,686,622 | +35% | +$16,199,997 | |||||
| D | 2025-10-28 | MLPT | Catalyst4, Inc. | 10% | P - Purchase | $17.00 | +5,441,176 | 19,697,464 | +38% | +$92,499,992 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |